Joan Fallon

CEO/Founder
Curemark

Dr. Joan Fallon, Founder and CEO of Curemark, is considered a visionary scientist who has dedicated her life’s work to championing the health and wellbeing of children worldwide. She is widely recognized for her vision, passion, and innovation in defining a successful entrepreneurial venture. Curemark is a biopharmaceutical company focused on the development of novel therapies to treat serious diseases for which there are limited treatment options. The company’s pipeline includes a phase III clinical-stage research program for Autism & ADHD, as well as three preclinical programs focused on Parkinson’s Disease, schizophrenia, and addiction. Joan holds 51 patents worldwide, has written numerous scholarly articles, and lectured extensively across the globe on pediatric developmental problems including autism. She is also a member of the Board of Trustees of Franklin & Marshall College.

Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.